Month: July 2018
Two national drug lobbying organizations dropped a lawsuit Thursday challenging the constitutionality of Nevada’s first-in-the-nation insulin pricing transparency law a little less than a month after the state approved regulations allowing drug companies to protect certain information they turn over to the state from public disclosure.
The guidance reflects concerns CMS has expressed regarding consumer complaints, including some about brokers. CMS is considering a program to advise individual brokers if they have received complaints or have reason to believe that a broker has not adhered to Marketplace rules. The program which is under review and has been described to NAHU would be advisory in nature and would not be reported to state regulators.
The number of registered brokers and agents who help people sign up for coverage through the federal ACA insurance exchange continued to decline in 2018, despite the CMS' efforts to encourage their participation by making it easier for them to sign up customers during open enrollment.
California legislators are giving companies dealing in personal data—including some health information—yet another set of restrictions to contend with thanks to a new broad privacy law passed last week.
Last year, as insurance prices rose by an average of just over 20 percent around the country, people who qualified for Obamacare subsidies hung onto their insurance. But the increases appear to have been too much to bear for many customers who earned too much to qualify for financial help.
President Trump may think top drugmakers are ready to step up with price cuts, but Pfizer, for one, is going the other way instead.
Insurance Commissioner Dave Jones announced today he has issued an order that every insurer licensed to write workers' compensation insurance in the State of California must report their federal income tax savings annually through a rate filing in light of the new tax law.
Billions of investment dollars have been poured into apps and websites that offer this virtual consultations with physicians, ranging from Doctor on Demand to American Well. The theory behind them is that millennials would opt for a digital alternative to an in-person physician's visit, if the option were available. And patients in remote, rural areas who are miles away from the nearest doctor would have few alternatives.
Doctors and teaching hospitals received $8.4 billion in payments from drug companies in 2017, according to the latest Open Payments data released by the Centers for Medicare & Medicaid Services.
Amazon.com Inc. is buying its way into the pharmacy business. Now the question is, how big can it get?